PL361929A1 - Medyczne i kosmetyczne zastosowanie chmielu i ko-enzymu Q 10 - Google Patents

Medyczne i kosmetyczne zastosowanie chmielu i ko-enzymu Q 10

Info

Publication number
PL361929A1
PL361929A1 PL36192902A PL36192902A PL361929A1 PL 361929 A1 PL361929 A1 PL 361929A1 PL 36192902 A PL36192902 A PL 36192902A PL 36192902 A PL36192902 A PL 36192902A PL 361929 A1 PL361929 A1 PL 361929A1
Authority
PL
Poland
Prior art keywords
enzyme
hops
medical
cosmetic use
composition
Prior art date
Application number
PL36192902A
Other languages
English (en)
Inventor
De Wiel Adriaan Emanuel Hendricus Anna Maria Van
Marijke Christiaans
Original Assignee
B.A.S.A.Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19772801&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL361929(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by B.A.S.A.Sarl filed Critical B.A.S.A.Sarl
Publication of PL361929A1 publication Critical patent/PL361929A1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/348Cannabaceae
    • A61K36/3486Humulus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • A61K8/355Quinones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
PL36192902A 2001-01-26 2002-01-24 Medyczne i kosmetyczne zastosowanie chmielu i ko-enzymu Q 10 PL361929A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1017205A NL1017205C2 (nl) 2001-01-26 2001-01-26 Medicinale en cosmetische toepassing van hop en co-enzym Q10.
PCT/NL2002/000054 WO2002078727A1 (en) 2001-01-26 2002-01-24 Medicinal and cosmetic use of hop and co-enzyme q10

Publications (1)

Publication Number Publication Date
PL361929A1 true PL361929A1 (pl) 2004-10-18

Family

ID=19772801

Family Applications (1)

Application Number Title Priority Date Filing Date
PL36192902A PL361929A1 (pl) 2001-01-26 2002-01-24 Medyczne i kosmetyczne zastosowanie chmielu i ko-enzymu Q 10

Country Status (6)

Country Link
EP (1) EP1359928B1 (pl)
AT (1) ATE312618T1 (pl)
DE (1) DE60207988D1 (pl)
NL (1) NL1017205C2 (pl)
PL (1) PL361929A1 (pl)
WO (1) WO2002078727A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101395370B1 (ko) * 2004-01-22 2014-05-14 유니버시티 오브 마이애미 국소용 코-엔자임 큐10 제형 및 그의 사용 방법
WO2006017494A2 (en) * 2004-08-02 2006-02-16 Elizabeth Mazzio Inhibition of anaerobic glucose metabolism
WO2007013556A1 (ja) * 2005-07-28 2007-02-01 Kaneka Corporation 癌予防用組成物
MX337408B (es) 2007-03-22 2016-03-03 Berg Llc Formulaciones topicas que tienen biodisponibilidad aumentada.
MX2010011032A (es) 2008-04-11 2011-03-01 Cytotech Labs Llc Star Metodos y uso de induccion de apoptosis en celulas cancerigenas.
CN102481271A (zh) 2009-05-11 2012-05-30 博格生物系统有限责任公司 利用表观代谢转变剂、多维细胞内分子或环境影响剂治疗代谢障碍的方法
SG10202010355PA (en) 2010-03-12 2020-11-27 Berg Llc Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
CA2832324C (en) 2011-04-04 2022-03-15 Berg Llc Methods of treating central nervous system tumors
EP2720680B1 (en) 2011-06-17 2020-02-12 Berg LLC Inhalable pharmaceutical compositions
NZ713868A (en) 2013-04-08 2021-12-24 Berg Llc Treatment of cancer using coenzyme q10 combination therapies
KR102370843B1 (ko) 2013-09-04 2022-03-04 버그 엘엘씨 코엔자임 q10의 연속주입에 의한 암치료 방법
CN104623453A (zh) * 2015-01-20 2015-05-20 刘保和 治疗妇女乳痰的药物制剂及制备
WO2017087576A1 (en) 2015-11-16 2017-05-26 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52145509A (en) * 1976-05-27 1977-12-03 Tokutarou Matsui Antitumor agent
CN1031021A (zh) * 1987-07-24 1989-02-15 天津市化妆品科学技术研究所 女性乳房健美化妆品

Also Published As

Publication number Publication date
WO2002078727A1 (en) 2002-10-10
NL1017205C2 (nl) 2002-07-29
EP1359928B1 (en) 2005-12-14
ATE312618T1 (de) 2005-12-15
DE60207988D1 (de) 2006-01-19
EP1359928A1 (en) 2003-11-12

Similar Documents

Publication Publication Date Title
PL361929A1 (pl) Medyczne i kosmetyczne zastosowanie chmielu i ko-enzymu Q 10
MY129809A (en) Quinazoline derivatives
GB0226931D0 (en) Chemical compounds
DE69724811D1 (de) Pentafluorobenzensulfonamide und analoge
CY1107862T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν παραγωγα οιστερολης για χρηση στη θεραπεια του καρκινου
MY136926A (en) Glucokinase activators
MXPA03006771A (es) Anticuerpos modificados y metodos de uso.
IL116385A0 (en) Sulphonamides their manufacture and pharmaceutical compositions containing them
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
PL367682A1 (pl) Pochodne dolastatyny 10
DE60045508D1 (de) Dalda-analoge und ihre verwendung
DE69713273D1 (de) Verwendung von 3,4-Diphenylchromanen zur Herstellung eines Arzneimittels zur Behandlung bzw. Vorbeugung des Prostatakarzinoms
BG106155A (en) Novel derivatives and analogues of galanthamin
YU68702A (sh) Novi lhrh-antagonisti, njihova proizvodnja i upotreba kao leka
DE60107272D1 (de) Eisenverbindungen
SE0003476D0 (sv) Compounds
DE69911017D1 (en) Arylsulfonanilid-phosphate
PL357999A1 (pl) Nowi antagoniści LHRH, ich wytwarzanie i zastosowanie jako środka leczniczego
YU46302A (sh) Supstituisani piroli
GB0314726D0 (en) New cytotoxic depsipeptides
AU2003236701A1 (en) Guanidino phenylalanin compounds used as urokinase inhibitors
AU4302996A (en) Uracil derivatives
DK1267902T3 (da) Kosmetisk anvendelse af humle og ornithin
NZ538926A (en) Medicament containing disorazoles and derivatives thereof for the treatment of benign and malignant tumoral diseases
MD1650F1 (en) 3,5-Dibromsalicylidenethiosemicarbazidopyridinecopper possessing antistaphylococcia and antistreptococcia activity

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)